Literature DB >> 31551514

Cyclooxygenase-2 is critical for the propagation of β-amyloid protein and reducing the glycosylation of tau in Alzheimer's disease.

Pei-Pei Guan1, Xin Yu2, Yan-Hui Zou1, Pu Wang3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31551514      PMCID： PMC6828724          DOI： 10.1038/s41423-019-0294-1

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  22 in total

Review 1.  Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.

Authors:  Claudio Soto; Lisbell Estrada; Joaquín Castilla
Journal:  Trends Biochem Sci       Date:  2006-02-13       Impact factor: 13.807

2.  A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.

Authors:  Scott A Yuzwa; Matthew S Macauley; Julia E Heinonen; Xiaoyang Shan; Rebecca J Dennis; Yuan He; Garrett E Whitworth; Keith A Stubbs; Ernest J McEachern; Gideon J Davies; David J Vocadlo
Journal:  Nat Chem Biol       Date:  2008-06-29       Impact factor: 15.040

3.  The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine.

Authors:  C S Arnold; G V Johnson; R N Cole; D L Dong; M Lee; G W Hart
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

4.  Cyclooxygenase-2 is Essential for Mediating the Effects of Calcium Ions on Stimulating Phosphorylation of Tau at the Sites of Ser 396 and Ser 404.

Authors:  Long-Long Cao; Pei-Pei Guan; Yun-Yue Liang; Xue-Shi Huang; Pu Wang
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

5.  Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation.

Authors:  Scott A Yuzwa; Xiaoyang Shan; Matthew S Macauley; Thomas Clark; Yuliya Skorobogatko; Keith Vosseller; David J Vocadlo
Journal:  Nat Chem Biol       Date:  2012-02-26       Impact factor: 15.040

6.  Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein.

Authors:  Arianna Bellucci; Andrew J Westwood; Esther Ingram; Fiorella Casamenti; Michel Goedert; Maria Grazia Spillantini
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

7.  Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.

Authors:  Yvonne S Eisele; Ulrike Obermüller; Götz Heilbronner; Frank Baumann; Stephan A Kaeser; Hartwig Wolburg; Lary C Walker; Matthias Staufenbiel; Mathias Heikenwalder; Mathias Jucker
Journal:  Science       Date:  2010-10-21       Impact factor: 47.728

8.  Glucose Metabolism: A Sweet Relief of Alzheimer's Disease.

Authors:  Claudia Duran-Aniotz; Claudio Hetz
Journal:  Curr Biol       Date:  2016-09-12       Impact factor: 10.834

9.  Magnesium ion influx reduces neuroinflammation in Aβ precursor protein/Presenilin 1 transgenic mice by suppressing the expression of interleukin-1β.

Authors:  Pu Wang; Xin Yu; Pei-Pei Guan; Jing-Wen Guo; Yue Wang; Yan Zhang; Hang Zhao; Zhan-You Wang
Journal:  Cell Mol Immunol       Date:  2015-11-09       Impact factor: 11.530

10.  Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.

Authors:  Juha Laurén; David A Gimbel; Haakon B Nygaard; John W Gilbert; Stephen M Strittmatter
Journal:  Nature       Date:  2009-02-26       Impact factor: 49.962
View more
  2 in total

Review 1.  History in Perspective: The prime pathological players and role of phytochemicals in Alzheimer's disease.

Authors:  Mohd Sajad; Rajesh Kumar; Sonu Chand Thakur
Journal:  IBRO Neurosci Rep       Date:  2022-04-28

2.  Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.

Authors:  Hamad Yadikar; Isabel Torres; Gabrielle Aiello; Milin Kurup; Zhihui Yang; Fan Lin; Firas Kobeissy; Richard Yost; Kevin K Wang
Journal:  PLoS One       Date:  2020-07-21       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.